Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | NR1H3 | Q13133 | 5/20 | 0.55 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.55 |
| ▸ | GRM5 | P41594 | 1/20 | 0.51 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.47 |
| ▸ | HIPK4 | Q8NE63 | 1/20 | 0.47 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5542353 | 0.87 | NR1H3 (0.52) | TDP1NR1H3NR1H2GRM5PIM3 | |
| SCHEMBL5538981 | 0.86 | TDP1 (0.62) | TDP1NR1H3PIM3HIPK4SCN2A | |
| SCHEMBL5582283 | 0.80 | TDP1 (0.48) | TDP1NR1H3NR1H2MEN1KMT2A | |
| SCHEMBL2687362 | 0.77 | NR1H3 (0.57) | TDP1NR1H3NR1H2PIM3HIPK4 | |
| SCHEMBL5541780 | 0.76 | TDP1 (0.51) | TDP1NR1H3NR1H2MEN1KMT2A | |
| SCHEMBL5582297 | 0.76 | NR1H3 (0.41) | TDP1NR1H3NR1H2GRM5PIM3 | |
| Benzyl Salicylate SCHEMBL1871397 | 0.75 | TDP1 (1.00) | TDP1KMT2AALDH1A1RAB9A | |
| Benzyl Salicylate SCHEMBL30184766 | 0.75 | TDP1 (1.00) | TDP1KMT2AALDH1A1RAB9A | |
| Benzyl Salicylate SCHEMBL15573 | 0.75 | TDP1 (1.00) | TDP1KMT2AALDH1A1RAB9A | |
| SCHEMBL10780057 | 0.75 | TDP1 (0.69) | TDP1MEN1KMT2AALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120115817-A1 | PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF-ALPHA MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES | EMS S.A. (BR) | 2012-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120115817-A1 | PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF-ALPHA MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES | TNF, PER2, CRY1 | TDP1 4039/4885NR1H3 585/4885NR1H2 398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.